nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Sorafenib—liver cancer	0.303	0.38	CbGbCtD
Dihydrocodeine—CYP3A4—Sorafenib—liver cancer	0.193	0.242	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—liver cancer	0.184	0.231	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—liver cancer	0.117	0.147	CbGbCtD
Dihydrocodeine—Mood swings—Sorafenib—liver cancer	0.00493	0.0374	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Sorafenib—liver cancer	0.0038	0.0288	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Sorafenib—liver cancer	0.00356	0.027	CcSEcCtD
Dihydrocodeine—Urethral disorder—Sorafenib—liver cancer	0.00353	0.0268	CcSEcCtD
Dihydrocodeine—Angiopathy—Sorafenib—liver cancer	0.00327	0.0248	CcSEcCtD
Dihydrocodeine—Immune system disorder—Sorafenib—liver cancer	0.00325	0.0247	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Sorafenib—liver cancer	0.00325	0.0246	CcSEcCtD
Dihydrocodeine—Mental disorder—Sorafenib—liver cancer	0.00316	0.0239	CcSEcCtD
Dihydrocodeine—Angioedema—Sorafenib—liver cancer	0.00287	0.0217	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00265	0.0201	CcSEcCtD
Dihydrocodeine—Dry mouth—Sorafenib—liver cancer	0.00261	0.0198	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Sorafenib—liver cancer	0.00251	0.019	CcSEcCtD
Dihydrocodeine—Skin disorder—Sorafenib—liver cancer	0.00249	0.0189	CcSEcCtD
Dihydrocodeine—Dyspnoea—Sorafenib—liver cancer	0.00228	0.0173	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00221	0.0168	CcSEcCtD
Dihydrocodeine—Constipation—Sorafenib—liver cancer	0.00219	0.0166	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Sorafenib—liver cancer	0.00209	0.0159	CcSEcCtD
Dihydrocodeine—Urticaria—Sorafenib—liver cancer	0.00203	0.0154	CcSEcCtD
Dihydrocodeine—Abdominal pain—Sorafenib—liver cancer	0.00202	0.0153	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—liver cancer	0.00189	0.0144	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—liver cancer	0.00182	0.0138	CcSEcCtD
Dihydrocodeine—Pruritus—Sorafenib—liver cancer	0.00181	0.0137	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—liver cancer	0.00175	0.0133	CcSEcCtD
Dihydrocodeine—Diarrhoea—Sorafenib—liver cancer	0.00175	0.0133	CcSEcCtD
Dihydrocodeine—Dizziness—Sorafenib—liver cancer	0.00169	0.0128	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—liver cancer	0.00169	0.0128	CcSEcCtD
Dihydrocodeine—Vomiting—Sorafenib—liver cancer	0.00163	0.0123	CcSEcCtD
Dihydrocodeine—Rash—Sorafenib—liver cancer	0.00161	0.0122	CcSEcCtD
Dihydrocodeine—Dermatitis—Sorafenib—liver cancer	0.00161	0.0122	CcSEcCtD
Dihydrocodeine—Headache—Sorafenib—liver cancer	0.0016	0.0122	CcSEcCtD
Dihydrocodeine—Nausea—Sorafenib—liver cancer	0.00152	0.0115	CcSEcCtD
Dihydrocodeine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00142	0.0198	CbGpPWpGaD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—liver cancer	0.0014	0.0106	CcSEcCtD
Dihydrocodeine—OPRM1—Peptide GPCRs—CCR4—liver cancer	0.00139	0.0194	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00136	0.019	CbGpPWpGaD
Dihydrocodeine—Urinary tract disorder—Epirubicin—liver cancer	0.00131	0.00997	CcSEcCtD
Dihydrocodeine—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00131	0.0183	CbGpPWpGaD
Dihydrocodeine—Urethral disorder—Epirubicin—liver cancer	0.00131	0.0099	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—liver cancer	0.0013	0.00984	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—liver cancer	0.00122	0.00923	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—liver cancer	0.00121	0.00916	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—liver cancer	0.00121	0.00916	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—liver cancer	0.0012	0.00912	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—liver cancer	0.0012	0.0091	CcSEcCtD
Dihydrocodeine—CYP2D6—Xenobiotics—CYP2E1—liver cancer	0.00119	0.0166	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—COL1A1—liver cancer	0.00118	0.0165	CbGpPWpGaD
Dihydrocodeine—Mental disorder—Epirubicin—liver cancer	0.00117	0.00885	CcSEcCtD
Dihydrocodeine—CYP2D6—Tamoxifen metabolism—CYP2E1—liver cancer	0.00114	0.016	CbGpPWpGaD
Dihydrocodeine—Angiopathy—Doxorubicin—liver cancer	0.00112	0.00848	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—liver cancer	0.00111	0.00844	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—liver cancer	0.00111	0.00842	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—liver cancer	0.00108	0.00819	CcSEcCtD
Dihydrocodeine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00106	0.0148	CbGpPWpGaD
Dihydrocodeine—Vertigo—Epirubicin—liver cancer	0.00104	0.0079	CcSEcCtD
Dihydrocodeine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00102	0.0142	CbGpPWpGaD
Dihydrocodeine—Convulsion—Epirubicin—liver cancer	0.001	0.00762	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00098	0.00743	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—liver cancer	0.000965	0.00732	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—liver cancer	0.000964	0.00731	CcSEcCtD
Dihydrocodeine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000963	0.0134	CbGpPWpGaD
Dihydrocodeine—Confusional state—Epirubicin—liver cancer	0.000954	0.00723	CcSEcCtD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000933	0.013	CbGpPWpGaD
Dihydrocodeine—Convulsion—Doxorubicin—liver cancer	0.000929	0.00705	CcSEcCtD
Dihydrocodeine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000929	0.013	CbGpPWpGaD
Dihydrocodeine—Nervous system disorder—Epirubicin—liver cancer	0.000928	0.00704	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—liver cancer	0.000919	0.00697	CcSEcCtD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000917	0.0128	CbGpPWpGaD
Dihydrocodeine—Hyperhidrosis—Epirubicin—liver cancer	0.000914	0.00694	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000907	0.00688	CcSEcCtD
Dihydrocodeine—CYP2D6—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000906	0.0126	CbGpPWpGaD
Dihydrocodeine—Dry mouth—Doxorubicin—liver cancer	0.000893	0.00677	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—liver cancer	0.000884	0.0067	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—liver cancer	0.000883	0.00669	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—liver cancer	0.000858	0.00651	CcSEcCtD
Dihydrocodeine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000858	0.012	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Xenobiotics—CYP1A1—liver cancer	0.000854	0.0119	CbGpPWpGaD
Dihydrocodeine—Skin disorder—Doxorubicin—liver cancer	0.00085	0.00645	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—liver cancer	0.000849	0.00644	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—liver cancer	0.000846	0.00642	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—liver cancer	0.000843	0.0064	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—liver cancer	0.000841	0.00638	CcSEcCtD
Dihydrocodeine—CYP2D6—Tamoxifen metabolism—CYP1A1—liver cancer	0.000821	0.0115	CbGpPWpGaD
Dihydrocodeine—Hypotension—Doxorubicin—liver cancer	0.000818	0.0062	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000817	0.00619	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—liver cancer	0.000809	0.00613	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—liver cancer	0.000786	0.00596	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—liver cancer	0.00078	0.00592	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—liver cancer	0.00078	0.00591	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—liver cancer	0.000778	0.0059	CcSEcCtD
Dihydrocodeine—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.000777	0.0108	CbGpPWpGaD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—liver cancer	0.000774	0.00587	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000756	0.00573	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—liver cancer	0.000751	0.0057	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—liver cancer	0.000748	0.00568	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—liver cancer	0.000748	0.00567	CcSEcCtD
Dihydrocodeine—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000747	0.0104	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000743	0.0104	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000734	0.0102	CbGpPWpGaD
Dihydrocodeine—Feeling abnormal—Doxorubicin—liver cancer	0.000721	0.00547	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000716	0.00543	CcSEcCtD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—BCL2L1—liver cancer	0.000697	0.00973	CbGpPWpGaD
Dihydrocodeine—Urticaria—Doxorubicin—liver cancer	0.000695	0.00527	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—liver cancer	0.000692	0.00525	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—liver cancer	0.000669	0.00508	CcSEcCtD
Dihydrocodeine—CYP2D6—Biological oxidations—UGDH—liver cancer	0.000668	0.00932	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000667	0.00931	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—MAPK14—liver cancer	0.00066	0.00921	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CCR4—liver cancer	0.000653	0.00911	CbGpPWpGaD
Dihydrocodeine—Diarrhoea—Epirubicin—liver cancer	0.000647	0.00491	CcSEcCtD
Dihydrocodeine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000641	0.00894	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—CYP1A1—liver cancer	0.000634	0.00885	CbGpPWpGaD
Dihydrocodeine—Dizziness—Epirubicin—liver cancer	0.000626	0.00474	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—liver cancer	0.000619	0.0047	CcSEcCtD
Dihydrocodeine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000607	0.00848	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—CD8A—liver cancer	0.000605	0.00844	CbGpPWpGaD
Dihydrocodeine—Vomiting—Epirubicin—liver cancer	0.000601	0.00456	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—liver cancer	0.000599	0.00454	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—liver cancer	0.000596	0.00452	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—liver cancer	0.000596	0.00452	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—liver cancer	0.000593	0.00449	CcSEcCtD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000592	0.00827	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000582	0.00812	CbGpPWpGaD
Dihydrocodeine—Dizziness—Doxorubicin—liver cancer	0.000579	0.00439	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—liver cancer	0.000562	0.00426	CcSEcCtD
Dihydrocodeine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000558	0.00779	CbGpPWpGaD
Dihydrocodeine—Vomiting—Doxorubicin—liver cancer	0.000556	0.00422	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—liver cancer	0.000552	0.00419	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—liver cancer	0.000551	0.00418	CcSEcCtD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CCR4—liver cancer	0.000551	0.00769	CbGpPWpGaD
Dihydrocodeine—Headache—Doxorubicin—liver cancer	0.000548	0.00416	CcSEcCtD
Dihydrocodeine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000537	0.00749	CbGpPWpGaD
Dihydrocodeine—Nausea—Doxorubicin—liver cancer	0.00052	0.00394	CcSEcCtD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.000511	0.00714	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000508	0.00709	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000494	0.00689	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—MAPK14—liver cancer	0.00049	0.00684	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000487	0.0068	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00048	0.0067	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—MTOR—liver cancer	0.000469	0.00654	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.000438	0.00611	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000437	0.00609	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.0004	0.00558	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000399	0.00557	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.00039	0.00544	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000384	0.00535	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000378	0.00528	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—RAF1—liver cancer	0.000356	0.00497	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000355	0.00495	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000351	0.0049	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00035	0.00488	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000346	0.00483	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000342	0.00477	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000334	0.00466	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CCR4—liver cancer	0.000334	0.00466	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.00033	0.0046	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000326	0.00455	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000323	0.0045	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000322	0.00449	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000318	0.00444	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—JUN—liver cancer	0.000311	0.00434	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—MAPK8—liver cancer	0.000294	0.00411	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000287	0.00401	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000287	0.004	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—PIK3CA—liver cancer	0.000286	0.00399	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000276	0.00385	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000273	0.00382	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000262	0.00365	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—F2—liver cancer	0.000261	0.00364	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000261	0.00364	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000255	0.00356	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CHN2—liver cancer	0.000254	0.00355	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000251	0.0035	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—TGFB1—liver cancer	0.000249	0.00348	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000247	0.00345	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—AKT1—liver cancer	0.000234	0.00326	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IFT88—liver cancer	0.000232	0.00324	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000232	0.00324	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000229	0.0032	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000229	0.00319	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000226	0.00316	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000224	0.00312	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000216	0.00301	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000213	0.00298	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000213	0.00297	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00021	0.00293	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.00021	0.00293	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—TRIO—liver cancer	0.000197	0.00274	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—HRAS—liver cancer	0.000196	0.00274	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000195	0.00272	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CCR4—liver cancer	0.000189	0.00263	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000188	0.00262	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL6—liver cancer	0.000188	0.00262	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000179	0.0025	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—TRIO—liver cancer	0.000179	0.00249	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000175	0.00245	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000175	0.00244	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—AKT1—liver cancer	0.000173	0.00242	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000173	0.00241	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCR4—liver cancer	0.000171	0.00239	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.00017	0.00238	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000161	0.00225	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000159	0.00222	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000153	0.00213	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000151	0.0021	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SHC3—liver cancer	0.000142	0.00199	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000139	0.00194	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000137	0.00191	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—F2—liver cancer	0.000133	0.00186	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000128	0.00178	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000115	0.0016	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UGDH—liver cancer	0.000114	0.00159	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000113	0.00158	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FST—liver cancer	0.000111	0.00154	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PRKCE—liver cancer	0.000109	0.00151	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—EPT1—liver cancer	0.000107	0.0015	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TRIO—liver cancer	0.000105	0.00147	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000105	0.00147	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000104	0.00145	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TAT—liver cancer	0.000102	0.00142	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCR4—liver cancer	0.000101	0.00141	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	9.98e-05	0.00139	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PRKCE—liver cancer	9.86e-05	0.00138	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	9.85e-05	0.00137	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CSF2—liver cancer	9.6e-05	0.00134	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CSF2—liver cancer	8.72e-05	0.00122	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADAM17—liver cancer	7.99e-05	0.00112	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—F2—liver cancer	7.54e-05	0.00105	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PSMA4—liver cancer	7.52e-05	0.00105	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PSMD10—liver cancer	7.52e-05	0.00105	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UGDH—liver cancer	7.47e-05	0.00104	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CG—liver cancer	7.21e-05	0.00101	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—EPT1—liver cancer	7.02e-05	0.00098	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CPT1B—liver cancer	6.92e-05	0.000966	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GLUL—liver cancer	6.92e-05	0.000966	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—F2—liver cancer	6.84e-05	0.000955	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NR1H4—liver cancer	6.67e-05	0.000931	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TAT—liver cancer	6.66e-05	0.000929	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA3—liver cancer	6.56e-05	0.000915	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—liver cancer	6.55e-05	0.000914	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	6.34e-05	0.000885	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA4—liver cancer	6e-05	0.000837	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA2—liver cancer	5.85e-05	0.000816	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCE—liver cancer	5.82e-05	0.000813	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	5.76e-05	0.000803	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA1—liver cancer	5.64e-05	0.000787	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NAT2—liver cancer	5.58e-05	0.000778	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	5.53e-05	0.000771	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF2—liver cancer	5.52e-05	0.00077	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALDOB—liver cancer	5.35e-05	0.000746	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CSF2—liver cancer	5.15e-05	0.000719	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—RAF1—liver cancer	5.14e-05	0.000717	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CRABP1—liver cancer	5.1e-05	0.000712	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—H2AFX—liver cancer	5.08e-05	0.000709	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2—liver cancer	5.08e-05	0.000708	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	5.02e-05	0.0007	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2—liver cancer	4.61e-05	0.000643	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TERT—liver cancer	4.59e-05	0.000641	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GLUL—liver cancer	4.52e-05	0.000631	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CPT1B—liver cancer	4.52e-05	0.000631	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HPGDS—liver cancer	4.46e-05	0.000622	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NR1H4—liver cancer	4.36e-05	0.000609	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA3—liver cancer	4.29e-05	0.000598	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KDR—liver cancer	4.2e-05	0.000586	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK14—liver cancer	4.17e-05	0.000582	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ESR1—liver cancer	4.09e-05	0.000571	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—F2—liver cancer	4.04e-05	0.000564	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PSMA4—liver cancer	3.97e-05	0.000555	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PSMD10—liver cancer	3.97e-05	0.000555	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA4—liver cancer	3.92e-05	0.000547	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—liver cancer	3.87e-05	0.00054	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APC—liver cancer	3.87e-05	0.00054	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GOT2—liver cancer	3.87e-05	0.000539	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA2—liver cancer	3.82e-05	0.000533	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA1—liver cancer	3.69e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAT2—liver cancer	3.65e-05	0.000509	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BRAF—liver cancer	3.64e-05	0.000507	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.63e-05	0.000507	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDOB—liver cancer	3.5e-05	0.000488	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CD—liver cancer	3.4e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYCS—liver cancer	3.4e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	3.37e-05	0.00047	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SERPINE1—liver cancer	3.36e-05	0.000469	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GGT1—liver cancer	3.34e-05	0.000466	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GOT1—liver cancer	3.34e-05	0.000466	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CRABP1—liver cancer	3.34e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KRAS—liver cancer	3.33e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	3.06e-05	0.000427	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAF1—liver cancer	3.04e-05	0.000424	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—liver cancer	3e-05	0.000418	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MTOR—liver cancer	2.96e-05	0.000414	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CB—liver cancer	2.96e-05	0.000414	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMOX1—liver cancer	2.96e-05	0.000413	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPGDS—liver cancer	2.92e-05	0.000407	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HRAS—liver cancer	2.83e-05	0.000395	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1B—liver cancer	2.78e-05	0.000388	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—liver cancer	2.75e-05	0.000384	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—liver cancer	2.75e-05	0.000384	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—liver cancer	2.73e-05	0.00038	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2—liver cancer	2.72e-05	0.00038	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—liver cancer	2.71e-05	0.000378	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCND1—liver cancer	2.65e-05	0.00037	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JUN—liver cancer	2.65e-05	0.00037	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CTNNB1—liver cancer	2.63e-05	0.000367	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.61e-05	0.000364	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PSMA4—liver cancer	2.6e-05	0.000363	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PSMD10—liver cancer	2.6e-05	0.000363	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—liver cancer	2.58e-05	0.00036	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1A—liver cancer	2.57e-05	0.000358	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GOT2—liver cancer	2.53e-05	0.000353	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK8—liver cancer	2.51e-05	0.00035	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—liver cancer	2.5e-05	0.000349	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—liver cancer	2.43e-05	0.00034	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARA—liver cancer	2.39e-05	0.000333	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.38e-05	0.000332	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—liver cancer	2.31e-05	0.000323	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—liver cancer	2.29e-05	0.00032	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYCS—liver cancer	2.22e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GOT1—liver cancer	2.18e-05	0.000304	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GGT1—liver cancer	2.18e-05	0.000304	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MYC—liver cancer	2.13e-05	0.000297	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—liver cancer	2.12e-05	0.000296	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—liver cancer	2.05e-05	0.000285	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARG—liver cancer	1.97e-05	0.000275	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KRAS—liver cancer	1.97e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—liver cancer	1.96e-05	0.000273	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMOX1—liver cancer	1.93e-05	0.00027	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CA—liver cancer	1.81e-05	0.000252	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—liver cancer	1.8e-05	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.8e-05	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—liver cancer	1.78e-05	0.000248	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—liver cancer	1.75e-05	0.000244	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.71e-05	0.000238	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HRAS—liver cancer	1.67e-05	0.000233	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—liver cancer	1.6e-05	0.000223	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—liver cancer	1.59e-05	0.000222	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.57e-05	0.000219	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARA—liver cancer	1.56e-05	0.000218	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—liver cancer	1.48e-05	0.000206	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.34e-05	0.000187	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARG—liver cancer	1.29e-05	0.00018	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.18e-05	0.000164	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—liver cancer	1.16e-05	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.02e-05	0.000143	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CA—liver cancer	9.55e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—liver cancer	7.8e-06	0.000109	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CA—liver cancer	6.25e-06	8.72e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—liver cancer	5.1e-06	7.12e-05	CbGpPWpGaD
